OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 90 filers reported holding OLEMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $161,791 | +304.6% | 17,917 | +9.8% | 0.02% | +240.0% |
| Q4 2022 | $39,989 | -25.9% | 16,322 | -16.9% | 0.01% | +25.0% |
| Q3 2022 | $54,000 | -67.7% | 19,652 | -52.0% | 0.00% | -71.4% |
| Q2 2022 | $167,000 | -34.5% | 40,946 | -31.6% | 0.01% | -33.3% |
| Q1 2022 | $255,000 | -64.7% | 59,824 | -22.5% | 0.02% | -67.2% |
| Q4 2021 | $723,000 | – | 77,203 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $103,181,000 | 7.44% |
| BVF INC/IL | 6,661,503 | $183,591,000 | 7.16% |
| VR Adviser, LLC | 1,536,193 | $42,337,000 | 5.44% |
| Cormorant Asset Management, LP | 3,073,485 | $84,705,000 | 3.44% |
| GREAT POINT PARTNERS LLC | 329,086 | $9,070,000 | 2.11% |
| Vivo Capital, LLC | 1,238,575 | $34,135,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 150,500 | $4,148,000 | 1.46% |
| Foresite Capital Management IV, LLC | 342,030 | $9,426,000 | 1.39% |
| RA Capital Management | 2,150,404 | $59,265,000 | 0.82% |
| SECTORAL ASSET MANAGEMENT INC | 338,381 | $9,326,000 | 0.78% |